rs758845090

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_014467.3(SRPX2):​c.646G>A​(p.Gly216Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,208,544 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G216G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000046 ( 0 hom. 2 hem. )

Consequence

SRPX2
NM_014467.3 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.65

Publications

0 publications found
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
SRPX2 Gene-Disease associations (from GenCC):
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polymicrogyria, bilateral perisylvian, X-linked
    Inheritance: XL Classification: LIMITED Submitted by: G2P
  • rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
    Inheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.29234874).
BP6
Variant X-100665356-G-A is Benign according to our data. Variant chrX-100665356-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 284208.
BS2
High AC in GnomAdExome4 at 5 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRPX2NM_014467.3 linkc.646G>A p.Gly216Ser missense_variant Exon 6 of 11 ENST00000373004.5 NP_055282.1 O60687

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRPX2ENST00000373004.5 linkc.646G>A p.Gly216Ser missense_variant Exon 6 of 11 1 NM_014467.3 ENSP00000362095.3 O60687

Frequencies

GnomAD3 genomes
AF:
0.00000891
AC:
1
AN:
112250
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000936
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000283
AC:
5
AN:
176767
AF XY:
0.0000324
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000185
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000456
AC:
5
AN:
1096294
Hom.:
0
Cov.:
32
AF XY:
0.00000553
AC XY:
2
AN XY:
361794
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26371
American (AMR)
AF:
0.000143
AC:
5
AN:
35042
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19353
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30123
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53637
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40399
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4132
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
841206
Other (OTH)
AF:
0.00
AC:
0
AN:
46031
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000891
AC:
1
AN:
112250
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34428
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30862
American (AMR)
AF:
0.0000936
AC:
1
AN:
10680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3566
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2660
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6202
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53211
Other (OTH)
AF:
0.00
AC:
0
AN:
1505
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Jan 07, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine with serine at codon 216 of the SRPX2 protein (p.Gly216Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with SRPX2-related disease. ClinVar contains an entry for this variant (Variation ID: 284208). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Dec 23, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.23
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.050
T;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.29
T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.2
L;.;.
PhyloP100
4.7
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.4
N;.;.
REVEL
Benign
0.19
Sift
Uncertain
0.028
D;.;.
Sift4G
Uncertain
0.021
D;.;.
Polyphen
0.95
P;.;.
Vest4
0.63
MutPred
0.65
Gain of glycosylation at G216 (P = 0.047);Gain of glycosylation at G216 (P = 0.047);.;
MVP
0.57
MPC
0.67
ClinPred
0.32
T
GERP RS
5.6
Varity_R
0.58
gMVP
0.64
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758845090; hg19: chrX-99920353; API